Literature DB >> 27478422

Noninvasive Facial Rejuvenation. Part 2: Physician-Directed-Neuromodulators and Fillers.

Ryan M Dickey1, Matthew R Louis1, Joshua A Cox1, Kriti Mohan1, Edward I Lee1, Marjory G Nigro2.   

Abstract

A proper knowledge of noninvasive facial rejuvenation is integral to the practice of a cosmetic surgeon. Noninvasive facial rejuvenation can be divided into patient- versus physician-directed modalities. Patient-directed facial rejuvenation combines the use of facial products such as sunscreen, moisturizers, retinoids, α-hydroxy acids, and various antioxidants to both maintain youthful skin as well as rejuvenate damaged skin. Physicians may recommend and often prescribe certain products, but patients are in control with this type of facial rejuvenation. On the other hand, physician-directed facial rejuvenation entails modalities that require direct physician involvement, such as neuromodulators, filler injections, laser resurfacing, microdermabrasion, and chemical peels. With the successful integration of each of these modalities, a complete facial regimen can be established and patient satisfaction can be maximized. This article is the second in a three-part series describing noninvasive facial rejuvenation. Here the authors discuss neuromodulators and fillers in detail, focusing on indications for use, techniques, and common side effects.

Entities:  

Keywords:  fillers; neuromodulators; noninvasive facial rejuvenation

Year:  2016        PMID: 27478422      PMCID: PMC4961509          DOI: 10.1055/s-0036-1584819

Source DB:  PubMed          Journal:  Semin Plast Surg        ISSN: 1535-2188            Impact factor:   2.314


  22 in total

1.  Botulinum toxin A in the mid and lower face and neck.

Authors:  Jean Carruthers; Alastair Carruthers
Journal:  Dermatol Clin       Date:  2004-04       Impact factor: 3.478

Review 2.  Dysport: pharmacological properties and factors that influence toxin action.

Authors:  Andy Pickett
Journal:  Toxicon       Date:  2009-03-28       Impact factor: 3.033

Review 3.  Dilution and storage of botulinum toxin.

Authors:  A W Klein
Journal:  Dermatol Surg       Date:  1998-11       Impact factor: 3.398

Review 4.  Injectable soft-tissue fillers: clinical overview.

Authors:  Barry L Eppley; Babak Dadvand
Journal:  Plast Reconstr Surg       Date:  2006-09-15       Impact factor: 4.730

5.  Comparison of botulinum toxin types A and B: a bilateral and double-blind randomized evaluation in the treatment of canthal rhytides.

Authors:  Seth L Matarasso
Journal:  Dermatol Surg       Date:  2003-01       Impact factor: 3.398

6.  Reduction in injection pain with botulinum toxin type B further diluted using saline with preservative: a double-blind, randomized controlled trial.

Authors:  S van Laborde; Jeffrey S Dover; Megan Moore; Brigitte Stewart; Kenneth A Arndt; Murad Alam
Journal:  J Am Acad Dermatol       Date:  2003-06       Impact factor: 11.527

7.  Treatment of HIV lipoatrophy and lipoatrophy of aging with poly-L-lactic acid: a prospective 3-year follow-up study.

Authors:  Ross M Levy; Kelley Pagliai Redbord; C William Hanke
Journal:  J Am Acad Dermatol       Date:  2008-12       Impact factor: 11.527

8.  Increased patient comfort utilizing botulinum toxin type a reconstituted with preserved versus nonpreserved saline.

Authors:  David M Kwiat; Thomas A Bersani; Adam Bersani
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2004-05       Impact factor: 1.746

Review 9.  Global Aesthetics Consensus: Botulinum Toxin Type A--Evidence-Based Review, Emerging Concepts, and Consensus Recommendations for Aesthetic Use, Including Updates on Complications.

Authors:  Hema Sundaram; Massimo Signorini; Steven Liew; Ada R Trindade de Almeida; Yan Wu; André Vieira Braz; Steven Fagien; Greg J Goodman; Gary Monheit; Hervé Raspaldo
Journal:  Plast Reconstr Surg       Date:  2016-03       Impact factor: 4.730

10.  ArteFill permanent injectable for soft tissue augmentation: I. Mechanism of action and injection techniques.

Authors:  Gottfried Lemperle; Terry R Knapp; Neil S Sadick; Stefan M Lemperle
Journal:  Aesthetic Plast Surg       Date:  2009-09-29       Impact factor: 2.326

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.